Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

MIT xPRO | Drug and Medical Device Development: A Strategic Approach - Online ProgramMIT xPRO | Drug and Medical Device Development: A Strategic Approach - Online Program
VS
UCLAUCLA
MIT xPRO | Drug and Medical Device Development: A Strategic Approach - Online Program

MIT xPRO | Drug and Medical Device Development: A Strategic Approach - Online Program

Cambridge, US

Last Update: 02/04/2026

View Profile
787/1000Fair

Digital disruption in healthcare has created opportunities for new data-driven and patient-centered products in the market. However, the process of bringing a new medical device or drug to market is highly complex due to additional layers of regulation. The Drug and M...

NAICS:6113
NAICS Definition:Colleges, Universities, and Professional Schools
Employees:None
Subsidiaries:179
12-month incidents
0
Known data breaches
0
Attack type number
0
UCLA

UCLA

405 Hilgard Ave, Los Angeles, CA, US, 90095-1405

Last Update: 02/04/2026

View Profile
Between 750 and 799
http://ucla.edu
761/1000Fair

UCLA offers a combination that’s rare, especially among public research universities. The breadth, depth and inspired excellence among academic programs—from the visual and performing arts to the humanities, social sciences, STEM disciplines and health sciences—add up t...

NAICS:6113
NAICS Definition:Colleges, Universities, and Professional Schools
Employees:29,011
Subsidiaries:50
12-month incidents
0
Known data breaches
0
Attack type number
1

Compliance Ranges Comparison

Based On Specific Ai Models Category
MIT xPRO | Drug and Medical Device Development: A Strategic Approach - Online Program

MIT xPRO | Drug and Medical Device Development: A Strategic Approach - Online Program

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
UCLA

UCLA

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Higher Education Industry Avg (This Year)

No incidents recorded for MIT xPRO | Drug and Medical Device Development: A Strategic Approach - Online Program in 2026.

Incidents

Incidents vs Higher Education Industry Avg (This Year)

No incidents recorded for UCLA in 2026.

Incidents

Incident History - MIT xPRO | Drug and Medical Device Development: A Strategic Approach - Online Program (X = Date, Y = Severity)

MIT xPRO | Drug and Medical Device Development: A Strategic Approach - Online Program cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - UCLA (X = Date, Y = Severity)

UCLA cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
MIT xPRO | Drug and Medical Device Development: A Strategic Approach - Online Program

MIT xPRO | Drug and Medical Device Development: A Strategic Approach - Online Program

Incidents
No explicit notable incidents reported.
UCLA

UCLA

Incidents
🔒 Incident : Ransomware
UCL0443723

FAQ

Between MIT xPRO | Drug and Medical Device Development: A Strategic Approach - Online Program company and UCLA company, which one has the best AI Cybersecurity Score ?
Between MIT xPRO | Drug and Medical Device Development: A Strategic Approach - Online Program company and UCLA company, which one has experienced more cyber incidents in the past ?
Between MIT xPRO | Drug and Medical Device Development: A Strategic Approach - Online Program company and UCLA company, which one has experienced more cyber incidents this year ?
Between MIT xPRO | Drug and Medical Device Development: A Strategic Approach - Online Program company and UCLA company, which one has experienced at least one ransomware attack ?
Between MIT xPRO | Drug and Medical Device Development: A Strategic Approach - Online Program company and UCLA company, which one has experienced at least one data breach ?
Between MIT xPRO | Drug and Medical Device Development: A Strategic Approach - Online Program company and UCLA company, which one has experienced at least one targeted cyberattack ?
Between MIT xPRO | Drug and Medical Device Development: A Strategic Approach - Online Program company and UCLA company, which one has experienced at least one vulnerability ?
Between MIT xPRO | Drug and Medical Device Development: A Strategic Approach - Online Program company and UCLA company, which one holds the most compliance certifications ?
Between MIT xPRO | Drug and Medical Device Development: A Strategic Approach - Online Program company and UCLA company, which one holds the fewest compliance certifications ?
Between MIT xPRO | Drug and Medical Device Development: A Strategic Approach - Online Program company and UCLA company, which one has the most subsidiaries ?
Between MIT xPRO | Drug and Medical Device Development: A Strategic Approach - Online Program company and UCLA company, which one has the largest number of employees ?
Between MIT xPRO | Drug and Medical Device Development: A Strategic Approach - Online Program and UCLA, which company holds both SOC 2 Type 1 certifications ?
Between MIT xPRO | Drug and Medical Device Development: A Strategic Approach - Online Program and UCLA, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - MIT xPRO | Drug and Medical Device Development: A Strategic Approach - Online Program or UCLA ?
Which company is PCI DSS compliant - MIT xPRO | Drug and Medical Device Development: A Strategic Approach - Online Program or UCLA ?
Between MIT xPRO | Drug and Medical Device Development: A Strategic Approach - Online Program and UCLA, which company complies with HIPAA regulations for healthcare data ?
Between MIT xPRO | Drug and Medical Device Development: A Strategic Approach - Online Program and UCLA, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-86544
SUMMARY

knowns versions before 0.30.0 contain an authorization bypass vulnerability where mutating code actions are incorrectly classified as read-only operations. Attackers with read-restricted sessions can exploit code.replace to modify permission configurations and escalate privileges on subsequent calls.

PUBLISHED
Date2026-09-07
UPDATED
Date2026-09-07
RISK INFORMATION (Score: 8.1)
CVSS3
Base Score: 8.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:H
CVSS4
Base Score: 7.2
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.2
EXPLOITABILITY
2.8
CVE-2026-86543
SUMMARY

knowns versions before 0.30.0 serve the management API without authentication on all network interfaces by default, with no password required on fresh installations. Attackers can access the unauthenticated /api/tunnel/start endpoint to provision a public tunnel and republish the API at a publicly accessible address.

PUBLISHED
Date2026-09-07
UPDATED
Date2026-09-07
RISK INFORMATION (Score: 9.8)
CVSS3
Base Score: 9.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
CVSS4
Base Score: 9.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
3.9
CVE-2026-86542
SUMMARY

knowns before 0.30.0 fails to validate import names in the import routes, allowing unauthenticated attackers to write files outside the imports directory. Attackers can supply traversal sequences in the name parameter to escape the imports directory and overwrite arbitrary files writable by the server process.

PUBLISHED
Date2026-09-07
UPDATED
Date2026-09-07
RISK INFORMATION (Score: 9.1)
CVSS3
Base Score: 9.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:H
CVSS4
Base Score: 8.8
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.2
EXPLOITABILITY
3.9
CVE-2026-86541
SUMMARY

knowns versions before 0.30.0 contain a path traversal vulnerability in the handleCodeReplace() function that allows attackers to overwrite arbitrary files outside the project root. Attackers can supply absolute paths or relative paths containing directory traversal sequences to write malicious content to sensitive files like shell startup scripts or SSH configuration files.

PUBLISHED
Date2026-09-07
UPDATED
Date2026-09-07
RISK INFORMATION (Score: 8.3)
CVSS3
Base Score: 8.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:H/A:H
CVSS4
Base Score: 7.2
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.5
EXPLOITABILITY
2.8
CVE-2026-86540
SUMMARY

knowns versions before 0.30.0 fail to validate the settings.lsp.languages binary field in project configuration files, allowing attackers to execute arbitrary binaries by crafting a malicious .knowns/config.json file. When a repository with a crafted configuration is opened, the unvalidated binary path is executed twice under the user's account without any verification.

PUBLISHED
Date2026-09-07
UPDATED
Date2026-09-07
RISK INFORMATION (Score: 7.8)
CVSS3
Base Score: 7.8
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
CVSS4
Base Score: 8.5
Complexity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:P/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
1.8